Screener
Axsome Therapeutics AXSM Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
FAQ
- What is Axsome Therapeutics's price / sales?
- Axsome Therapeutics (AXSM) reported price / sales of 12.2× in Q1 2026.
- How has Axsome Therapeutics's price / sales changed year-over-year?
- Axsome Therapeutics's price / sales decreased by 7.2% year-over-year, from 13.2× to 12.2×.
- What is the long-term trend for Axsome Therapeutics's price / sales?
- Over 3 years (2022 to 2025), Axsome Therapeutics's price / sales has grown at a -40.1% compound annual growth rate (CAGR), from 67× to 14.4×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Axsome Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude